Related Experiment Video

Updated: Jan 7, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K

Mitochondrial citrate transport represents a metabolic liability in MYCN-amplified neuroblastoma

Chan Chen1, Qing Bao2, Hao Huang1

  • 1Department of Urology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430071, China.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|January 4, 2026
PubMed

Insights

MYCN amplification in neuroblastoma drives cancer cell survival by regulating mitochondrial citrate export. Inhibiting Solute Carrier Family 25 Member 1 (SLC25A1) triggers apoptosis and enhances therapy, offering new treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Pathways

Background:

  • MYCN amplification is a key driver of aggressive neuroblastoma, conferring poor prognosis and therapeutic resistance.
  • Targeting MYCN directly has proven challenging, necessitating alternative therapeutic strategies.
  • MYCN's influence on cellular metabolism presents potential vulnerabilities for drug development.

Purpose of the Study:

  • To identify metabolic vulnerabilities in MYCN-amplified neuroblastomas.
  • To investigate the role of mitochondrial citrate export in MYCN-driven neuroblastoma.
  • To evaluate SLC25A1 as a therapeutic target for neuroblastoma.

Main Methods:

  • Investigated Solute Carrier Family 25 Member 1 (SLC25A1) mediated mitochondrial citrate export.
  • Analyzed the generation of Acetyl-CoA for histone and non-histone protein acetylation.
  • Assessed the impact of SLC25A1 inhibition on apoptosis and therapeutic efficacy in neuroblastoma cells.

Main Results:

  • SLC25A1-mediated citrate export is essential for MYCN-amplified neuroblastoma cell survival.
  • Citrate export supports Acetyl-CoA production, driving anti-apoptotic gene BIRC3 and MCL1 acetylation.
  • Inhibition of SLC25A1 induced significant apoptosis in MYCN-amplified neuroblastoma cells.
  • SLC25A1 inhibition synergized with BCL2 antagonists, enhancing therapeutic effects.

Conclusions:

  • SLC25A1 is a critical metabolic liability in MYCN-amplified neuroblastomas.
  • Targeting SLC25A1 represents a promising therapeutic strategy for neuroblastoma.
  • Combination therapy with SLC25A1 inhibitors and BCL2 antagonists shows potential for treating MYCN-amplified neuroblastomas.
Keywords:
MYCNSLC25A1acetyl-CoAcitrate transportcombination therapyoncogenesolid tumorstumor metabolismtumor-targeting strategies

More Related Videos

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers10:31

Three-dimensional Imaging and Analysis of Mitochondria within Human Intraepidermal Nerve Fibers

Published on: September 29, 2017

10.6K
Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

8.2K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.8K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.5K